BridgeBio Pharma's chart data is dated 2026-10-09. There is no active technical signal. There are 1 published signal records.
BridgeBio Pharma last closed at $65.35 (+0.48%) on 2026-10-09. Listed on Nasdaq. Trailing 12 months PER is -18.3×. Its overall grade ranks 65 of 738 stocks in Healthcare.
About this company
BridgeBio Pharma last closed at $65.35 (+0.48%) on 2026-10-09. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall A+ · 65/738
Valuation grade A+
Related stocks
- NovartisCompetitor
희귀질환·유전질환 치료제 영역에서 경쟁하는 글로벌 제약사
- PfizerCompetitor
동일 치료영역의 상업화·임상 개발에서 경쟁하는 대형 제약사
- SanofiCompetitor
희귀질환 및 유전질환 치료제 분야의 주요 경쟁사
ETFs holding this stock
Franklin Genomic Advancements ETF
Details →About BridgeBio Pharma
- What technical signals does BridgeBio Pharma (BBIO) have?
- BridgeBio Pharma current technical signals: no active technical signal.
- Is BridgeBio Pharma a cup-and-handle pattern?
- No. BridgeBio Pharma has no valid Cup signal right now.
- What published figures are available for BridgeBio Pharma?
- Market cap: $12.59B. Trailing 12 months PER: -18.3×. Latest quarter PBR: -5.08×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-09 dataset
Turn what you saw on this name into a strategy
Ask Q about BridgeBio Pharma, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.